Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions ...

CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...

Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over ...

Fintel reports that on May 6, 2024, Craig-Hallum initiated coverage of Eton Pharmaceuticals (NasdaqGM:ETON) with a Buy recommendation. Analyst Price Forecast Suggests 172.00% Upside As of May 2, 2024, ...

Beyond a doubt, Vancouver-based Acuitas Therapeutics, Inc. punches above its weight. It is the global leader in developing lipid nanoparticle (LNP) delivery technology for nucleic acid ...

Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for ...

CureVac continues to advance its clinical development programs in prophylactic vaccines in collaboration with GSK. All currently tested candidates apply modified mRNA and are based on CureVac’s ...

Expectations soar with raised 2024 EPS and sales forecasts. Vandana Singh COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle Acuitas Therapeutics ...

Acuitas previously secured a separate license for the lipid nanoparticle technology used in Pfizer/BioNTech's COVID-19 vaccine. Acuitas said CureVac omitted its scientists from patent ...